Online First

CASE REPORT SARS-CoV-2 infection in the immediate post-transplant period: A report of five kidney transplant recipients Luís Leite de Sousa, Afonso Santos, Anna Lima, Célia Nascimento, Cristina Jorge, Margarida Bruges, Teresa Adragão, André Weigert
The severe acute respiratory syndrome coronavirus 2 pandemic caused a negative impact on transplantation worldwide. One of the complexities is the management of the immunosuppression and anti-viral medication in transplant recipients. Herein we describe our experience managing five patients with coronavirus disease 2019 (COVID-19) immediately after kidney transplant.
Port J Nephrol Hypert 2022; 36(1): 3-6 Advance Access publication 21 March 2022 DOWNLOAD PDF
CASE REPORT Membranoproliferative glomerulonephritis: A rare pediatric nephropathy Andreia Marinhas, Telma Luís, Catarina Neves, Carmen Carmo, Clara Gomes
Membranoproliferative glomerulonephritis (MPGN) is a rare, chronic glomerulonephritis in pediatric age.
Port J Nephrol Hypert 2022; 36(1): 7-10 Advance Access publication 21 March 2022 DOWNLOAD PDF
CASE REPORT Thrombotic microangiopathy in a patient with a poorly controlled human immunodeficiency virus infection ? A clinical case Pedro Almiro e Castro, Nuno Afonso Oliveira, Rui Alves
hrombotic microangiopathy (TMA) includes a group of disorders characterized by microangiopathic haemolytic anaemia, thrombocy- topenia and microthrombi leading to ischaemic tissue injury, mainly in the brain and kidney.
Port J Nephrol Hypert 2022; 36(1): 11-14 Advance Access publication 21 March 2022 DOWNLOAD PDF
CASE REPORT The urine as a diagnostic key for a homozygous EGFR mutation Mafalda Casinhas Santos, Margarida Almendra, Sofia Bota, Helena Ramos, Telma Francisco
Epidermal Growth Factor Receptor (EGFR) signalling is crucial for proliferation control and cellular differentiation, mainly of the epithelial cells, and is directly implicated in epithelial tumor development
Port J Nephrol Hypert 2022; 36(1): 15-19 Advance Access publication 21 March 2022 DOWNLOAD PDF
CASE REPORT A minimal change disease (MCD) related nephrotic syndrome preceding a Hodgkin Lymphoma diagnosis ? A case report Pedro Almiro e Castro, Nuno Afonso Oliveira, Rui Alves
Minimal change disease (MCD) is a disorder characterized by podocyte foot process effacement and loss of the glomerular anionic charge. Such lesions cause selective protein leaks (mainly albumin) to the urine, causing a nephrotic syndrome.
Port J Nephrol Hypert 2022; 36(1): 20-24 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE Cardiovascular risk factors in pediatric kidney transplant recipients Margarida Cunha, Ana Gusmão Palmeiro, Ana Rita Sandes, Rosário Stone
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in chronic kidney disease (CKD) patients. 
Port J Nephrol Hypert 2022; 36(1): 25-30 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE Case series of COVID-19 in chronic kidney disease patients under peritoneal dialysis at a northern Portuguese center Rui F. Silva, Luís Mendonça, Luciano Pereira, Ana Beco
In December 2019, a cluster of pneumonia cases in Wuhan, China, were linked to a previously unknown coronavirus, severe acute res- piratory syndrome coronavirus 2 (SARS-COV-2). 
Port J Nephrol Hypert 2022; 36(1): 31-34 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE Predictors of hyporesponsiveness to erythropoietin in prevalent hemodialysis patients and its association with mortality Marisa Roldão, Rui Duarte, Rachele Escoli, Hernâni Gonçalves, Flora Sofia, Karina Lopes
Anemia is a common complication associated with increased morbidity and mortality in patients with end-stage renal disease (ESRD) on hemodialysis (HD).
Port J Nephrol Hypert 2022; 36(1): 35-39 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE Early mortality in incident hemodialysis patients ? A retrospective case-control study Rita Veríssimo, Luís Leite de Sousa, Tiago J. Carvalho, Pedro Fidalgo
Cronic kidney disease (CKD) is known to have significant morbi- mortality worldwide
Port J Nephrol Hypert 2022; 36(1): 40-45 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE Low income is associated with late nephrology referral in Portugal: A retrospective study Rui Duarte, Filipa Trigo, Ivan Luz, Paulo Santos, Karina Lopes, Hernâni Gonçalves, Flora Sofia, Ana Vila Lobos
Socioeconomic status (SES) is an important health determinant encompassing several dimensions, namely education, occupation and income.
Port J Nephrol Hypert 2022; 36(1): 46-49 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE SARS-CoV-2 antibody responses in infection-naive or previously infected peritoneal dialysis patients after 2 doses of the BNT162b2 vaccine Rui Silva, Filipa Silva, Luís Mendonça, Luciano Pereira, Ana Oliveira, Angélica Ramos, Maria João Cardoso, Ana Malheiro, João Tiago Guimarães
A two-dose regimen of the Pfizer/BioNTech SARS-CoV-2 mRNA vac- cine (BNT162b2) demonstrated 95% efficacy against Coronavirus disease 19 (Covid-19)(1), but end-stage kidney disease patients were not rep- resented in this population
Port J Nephrol Hypert 2022; 36(1): 50-52 Advance Access publication 21 March 2022 DOWNLOAD PDF
ORIGINAL ARTICLE Point-of-care ultrasound in peritoneal dialysis catheter-related infection: An observational study Hugo Diniz, Rui Silva, Ana Oliveira, Luciano Pereira, Ana Beco
Point-of-care ultrasound (POCUS) is an emerging bedside discipline that aims to enhance physical examination findings with real-time information from the ultrasound. 
Port J Nephrol Hypert 2022; 36(1): 53-56 Advance Access publication 21 March 2022 DOWNLOAD PDF
REVIEW ARTICLE Oral anticoagulation in patients with atrial fibrillation and end-stage kidney disease Tânia B. Azevedo, Sofia Correia
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with an estimated prevalence between 2 and 4%(1), worldwide, and a ten- dency for the incidence rate to increase(2,3).
Port J Nephrol Hypert 2022; 36(1): 57-64 Advance Access publication 21 March 2022 DOWNLOAD PDF
CASE REPORT Penicillamine-induced membranous nephropathy in an adolescent with Wilson?s disease Catarina Fernandes, Mariana Duarte, Patrícia Ferreira, Cristina Gonçalves, Ana Paula Serrão, Rute Baeta Baptista
Membranous nephropathy may present in any age group. While it is one of the most common causes of adult nephrotic syndrome, it is a rare histologic entity in the paediatric population. In adults it is more commonly classified as primary or idiopathic. In contrast, among children and adolescents, it is more frequently secondary to systemic disorders or drug exposures. One of the potentially implicated drugs is penicil- lamine, which has long been used as first-line therapy for symptomatic children with Wilson’s disease. We report a case of an adolescent treated with penicillamine for Wilson’s disease, who presented with overt nephrotic syndrome due to membranous nephropathy. As most of our knowledge about children and adolescents with membranous nephropathy has been based on extrapolations from adult studies, paediatric case reports may provide useful insights. We also aimed to emphasize the importance of proteinuria close monitoring in patients under treat- ment with penicillamine to allow for timely consideration of the drug withdrawal.
Port J Nephrol Hypert 2022; 36(2): 111-115 Advance Access publication 15 June 2022
CASE REPORT Forearm arteriovenous fistula maturation delay due to juxta-anastomotic stenosis: Role of percutaneous angioplasty Rui Filipe Nogueira, Nuno Afonso Oliveira, Emanuel Ferreira, Luís Rodrigues, Helena Pinto, Ana Belmira, Rui Alves
Arteriovenous fistula is the optimal vascular access for hemodialysis as it has the best long-term patency rate and the lowest complication rate. Although we are still lacking consensus, surgery has been advocated as the best treatment option for maturation delay. We proposed to evaluate the results of endovascular approach of arteriovenous fistula’s maturation delay in our hospital. Methods: We conducted a retrospective study, selecting patients referred to our diagnostic and therapeutic angiography unit due to arteriovenous fistula delayed matu- ration, between April 2017 and June 2020.
Port J Nephrol Hypert 2022; 36(2): 105-109 Advance Access publication 15 June 2022
CASE REPORT An atypical presentation of Ormond's disease João Carvão, Carlota Vida, Luís Resende, Francisca Silva, Gil Silva
Retroperitoneal fibrosis is a rare condition defined by an overproduction of fibro-inflammatory tissue in the retroperitoneum, usually involving the abdominal aorta, but also managing to invade adjacent structures.
Port J Nephrol Hypert 2021; 35(4): 231-233 Advance Access publication xx December 2021 DOWNLOAD PDF
ORIGINAL ARTICLE The very elderly followed at a nephrology center: metabolic acidosis as a predictor of progressive chronic kidney disease Marina Reis, Catarina Almeida, Catarina Ribeiro, Daniela Alferes, Ana Marta Gomes, João Carlos Fernandes
Chronic kidney disease is an increasingly common diagnosis in the very elderly and identifying the patients who benefit from a nephrologist’s intervention and the ones who would not might avoid wasteful or harmful interventions.
Port J Nephrol Hypert 2021; 35(2): 84-88 Advance Access publication 20 June 2021 DOWNLOAD PDF
REVIEW ARTICLE Mineral and bone disease in renal transplantation Ana Carina Ferreira, Aníbal Ferreira
Chronic kidney disease – mineral and bone disorders (CKD‑MBD) tends to improve or to change phenotypically in the post‑transplant period.
Port J Nephrol Hypert 2021; 35(2): 111-113 Advance Access publication 20 June 2021 DOWNLOAD PDF
REVIEW ARTICLE Sarcopenia in chronic kidney disease - A brief review Beatriz Donato, Catarina Teixeira, Sónia Velho, Edgar Almeida
Sarcopenia is a progressive age‑related loss of muscle mass associated with a decline in muscle function and physical performance.
Port J Nephrol Hypert 2021; 35(2): 99-105 Advance Access publication 20 June 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Peritoneal access - a pressing problem Patrícia Valério, Maria João Carvalho, Olívia Santos, António Cabrita, Anabela Rodrigues
In Portugal, as well as in Europe, peritoneal dialysis (PD) use remains low.
Port J Nephrol Hypert 2021; 35(2): 89-92 Advance Access publication 8 July 2021 DOWNLOAD PDF
NEPHROPATHOLOGY QUIZ Isolated microscopic hematuria: a world of possibilities Anna Lima, Afonso Santos, Ana Catarina Brás, Rita Theias, Patrícia Carrilho, Pedro Campos
We present the case of a 41-year-old South American female who was referred for nephrological evaluation due to persistent microscopic hematuria.
Port J Nephrol Hypert 2021; 35(2): 128-130 Advance Access publication 29 June 2021 DOWNLOAD PDF
PERSPECTIVE Surgical role in the management of peritoneal dialysis catheters - evidence and proposals to improve current practices Rita Vicente, Rui Silva, Ricardo Santos, Anabela Rodrigues, Manuel Amoedo
Peritoneal dialysis (PD) relies on adequate function of PD catheter.
Port J Nephrol Hypert 2021; 35(2): 69-74 Advance Access publication 29 june 2021 DOWNLOAD PDF
PERSPECTIVE Why the incidence in dialysis in the Lisbon and Tagus Valley Region (LVTR) is two to three times higher than in other regions of the country M. Martins Prata
The analysis of data from the Ministry of Health’s Integrated Chronic Kidney Disease Management Platform (PI‑GID), reveals the existence of a striking regional difference in the incidence in dialysis.
Port J Nephrol Hypert 2021; 35(2): 75-81 Advance Access publication 29 June 2021 DOWNLOAD PDF
PERSPECTIVE Reflections on the portuguese nephrology fellowship program in 2021. Nephrology fellowship training at a crossroads Artur Mendes
Nephrology is facing a period of remarkable and unprecedented change.
Port J Nephrol Hypert 2021; 35(2): 82-83 Advance Access publication 29 June 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Is COVID-19 that different in hemodialysis patients?: A single-center experience Marina Reis, Catarina Almeida, Ana Ventura, Catarina Ribeiro, Ana Marta Gomes, Daniela Lopes, Clara Santos, Sónia Sousa, João Carlos Fernandes
Coronavirus disease 2019 (COVID-19) has affected millions worldwide, and in particular the care of patients on maintenance hemodialysis.
Port J Nephrol Hypert 2021; 35(2): 93-98 Advance Access publication 29 June 2021 DOWNLOAD PDF
LETTER TO THE EDITOR The golden generation in Portuguese nephrology: fact or fiction? Marco Mendes
The score of 19 has become trivialized during Nephrology residence evaluation or as a final exam grade for some time.
Port J Nephrol Hypert 2021; 35(2): 131 Advance Access publication 29 June 2021 DOWNLOAD PDF
REVIEW ARTICLE Infection, immunosuppression, and treatment of auto-immune inflammatory kidney disease Diana Póvoas
Immunosuppressive drugs are the cornerstone of treatment of auto-immune inflammatory diseases (AIIDs) with renal involvement.
Port J Nephrol Hypert 2021; 35(3): 170-178 Advance Access publication 21 September 2021 DOWNLOAD PDF
COMMENT Madrid at the center of the Spanish COVID-19 pandemic: the result of ill-advised political decision-making Alberto Ortiz
In this issue of the Portuguese Journal of Nephrology and Hypertension, Deira et al report on the epidemiology of coronavirus disease 2019 (COVID-19) in Spanish dialysis units outside the largest cities.
Port J Nephrol Hypert 2021; 35(3): 205-206 Advance Access publication 21 September 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Covid-19 in 40 dialysis facilities. A prospective multicenter cohort study in Spain Javier L. Deira, Silvia González-Sanchidrián, André Rocha, Carlos G. Musso, Rosa M. Ruiz-Calero, Suleyka Puello, Belén Gómez, Manuel Ramos, George Stefan, Francisca Lopez, Eduardo Torregrosa, José L.
Aims: Assess the incidence of COVID-19 during the first wave of the pandemic in 40 hemodialysis units in Spain.
Port J Nephrol Hypert 2021; 35(3): 153-159 Advance Access publication 24 September 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Hemodialysis vascular access in children - A retrospective study in a pediatric dialysis unit Gabriela Teixeira, Paulo Almeida, A Norton de Matos, Maria Sameiro Faria, Madalena Gama, Luís Loureiro, Duarte Rego, Inês Antunes, Fernanda Silva, José Queirós, Rui Almeida
Objective: Permanent access in the form of a fistula is the preferred form of vascular access for most pediatric patients on maintenance...
Port J Nephrol Hypert 2021; 35(3): 160-163 Advance Access publication 21 September 2021 DOWNLOAD PDF
PERSPECTIVE Choices for life: how can we help? Ana Farinha
Fifty years ago, Portugal lived under a dictatorship. A significant number of people were illiterate and there was no health care system to support the sick.
Port J Nephrol Hypert 2021; 35(3): 137-141 Advance Access publication 27 September 2021 DOWNLOAD PDF
PERSPECTIVE The use of renin-angiotensin-aldosterone system inhibitors in chronic kidney disease: Is there any doubt? Ana Carina Ferreira
Renin‑Angiotensin‑Aldosterone system (RAAS) is of utmost importance in volume and blood pressure control, as well in sodium homeostasis.
Port J Nephrol Hypert 2021; 35(3): 142-143 Advance Access publication 21 September 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Antenatal hydronephrosis: a five-year retrospective study Maria J. Gaia, Mariana Capela, Margarida Peixoto, Joana P. Borges, Graça Ferreira
Introduction: Antenatal hydronephrosis (ANH) is common in fetal ultrasounds.
Port J Nephrol Hypert 2021; 35(3): 164-169 Advance Access publication 21 September 2021 DOWNLOAD PDF
ORIGINAL ARTICLE The Kidney Genetics Clinic: delivering precision medicine for kidney patients Joaquim Calado, Rui Barata, Rita Lucas, Telma Francisco, Rui Gonçalves, Nuno Carrilho Ribeiro, Fernando Nolasco
Molecular genetic testing in human traits has traditionally relied on affiliated academic facilities, been focused on specific phenotypes and supported by research funding.
Port J Nephrol Hypert 2021; 35(3): 144-152 Advance Access publication 22 September 2021 DOWNLOAD PDF
CASE REPORT Acute kidney injury associated with COVID-19 infection: a case report Tiago Duarte, Fernando Caeiro, Mário Góis, António Matos, Helena Viana, César Vieira, Jorge Paulos, Paulo Paixão, Bruno Matos, Nuno Germano, Fernando Nolasco
SARS-Cov2 infection is a highly transmissible disease associated with serious pulmonary disease.
Port J Nephrol Hypert 2021; 35(3): 192-195 Advance Access publication 27 September 2021 DOWNLOAD PDF
CASE REPORT Alagille Syndrome: An ultrafiltration dilemma Catarina Abrantes, Teresa Furtado, Patrícia Domingues, Patrícia Valério, Joana Felgueiras, José Assunção, Álvaro Vaz
Alagille syndrome (AGLS) is a rare genetic disorder caused by mutations in the Notch signaling pathway.
Port J Nephrol Hypert 2021; 35(3): 203-204 Advance Access publication 29 September 2021 DOWNLOAD PDF
CASE REPORT Hypertension as an atypical presentation of unilateral ureteral obstruction Pedro Mantas, Rute Baeta Baptista, Raquel Santos, Ana Paula Serrão
Ureteral obstruction (ureteropelvic or ureterovesical junction obstruction) is frequently diagnosed during the workup investigation of an asymptomatic infant or chil with upper urinary tract dilatation, commonly identified in a prenatal ultrasound.
Port J Nephrol Hypert 2021; 35(3): 196-202 Advance Access publication 29 September 2021 DOWNLOAD PDF
NEPHROPATHOLOGY QUIZ Renal biopsy: still a game changer Catarina Abrantes, Patrícia Valério, Teresa Furtado, Elsa Soares, Patrícia Domingues, Lúcia Parreira, Mário Góis, Helena Sousa
We report the case of a melanodermic 55-year-old male patient admitted to the emergency department with headache and vomiting for less than 24 hours.
Port J Nephrol Hypert 2021; 35(3): 207-209 Advance Access publication 29 September 2021 DOWNLOAD PDF
REVIEW ARTICLE Heart failure on peritoneal dialysis: Where do we stand? Marina Reis, Catarina Almeida, Ana Marta Gomes, João Carlos Fernandes
Cardiovascular disease continues to be the most frequent cause of death in peritoneal dialysis patients and an important obstacle for the improvement of technique survival.
Port J Nephrol Hypert 2021; 35(3): 179-185 Advance Access publication 29 September 2021 DOWNLOAD PDF
REVIEW ARTICLE New perspectives on the approach to patients with atypical Hemolytic Uremic Syndrome, candidates for renal transplantation Ana Carolina Figueiredo, Nuno Afonso Oliveira, Catarina Romãozinho, Helena Sá, Arnaldo Figueiredo, Rui Alves
Atypical hemolytic uremic syndrome (aHUS) is one of the most challenging diseases for a nephrologist, with high rates of progression to end‑stage kidney disease (ESKD) and post-transplant recurrence.
Port J Nephrol Hypert 2021; 35(3): 209-214 Advance Access publication 29 September 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Clinical impact of personalized sodium prescriptions in hemodialysis Mariana Sousa, Cristina Santos, Susana Colaço, José Paulo Santos, Jorge Silva
Dialysate sodium prescription is often standardized. In some patients, this can be hypernatremic compared to serum sodium, causing a positive sodium balance at the end of treatment that will contribute to increased extracellular volume and interdialytic weight gain.
Port J Nephrol Hypert 2021; 35(4): 215-221 Advance Access publication 20 December 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Renal biopsy in diabetic patients: Histopathological and clinical correlations Joana Paixão, Ana Carolina Pimenta, Luís Rodrigues, David Sousa, Sandra Santos, Emanuel Ferreira, Nuno Afonso, Fátima Costa, Vitor Sousa, Jorge Pratas, Rui Alves
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide.
Port J Nephrol Hypert 2021; 35(4): 226-230 Advance Access publication 20 December 2021 DOWNLOAD PDF
PERSPECTIVE Digital tools towards transplant first policy: Improving health literacy Daniela R. Nogueira, Manuela Almeida, Anabela S. Rodrigues
End stage kidney disease (ESKD) is a prevalent health issue across the world and it is well established that kidney transplantation (KT), specifically from a living donor, is currently the best value-based treatment method.
Port J Nephrol Hypert 2021; 35(4): 234-236 Advance Access publication xx December 2021 DOWNLOAD PDF
REVIEW ARTICLE Immune dysfunction in chronic kidney disease Sara Cardoso Fernandes, Ana Carina Ferreira
Chronic kidney disease is characterized by immune dysfunction that increases predisposition to infections, virus-associated cancers and impaired response to vaccination.
Port J Nephrol Hypert 2021; 35(4): 222-225 Advance Access publication 20 December 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Living kidney donation and reasons for denial: A report from a Brazilian single-center cross-sectional study Anna Lima, Lúcio R. Requião-Moura, Melissa Gaspar, José Medina-Pestana
Chronic kidney disease is increasingly more prevalent worldwide, and kidney transplant remains the best option for patient survival.
Port J Nephrol Hypert 2021; 35(4): 237-240 Advance Access publication xx December 2021 DOWNLOAD PDF
ORIGINAL ARTICLE Risk factors associated with hospitalization and evolution in kidney transplant patients with COVID-19: A single-center retrospective cohort study Isabel Beneyto Castelló, Elena Moreno Maestre, David Ramos Escorihuela, Jordi Espí Reig, Ana Ventura Galiano, María Ramos Cebrián, Marta Moreno Espinosa, Pablo González-Calero Borrás, Julio Hernández
Background: The SARS‑CoV‑2 infection has had a major impact on kidney transplant patients.
Port J Nephrol Hypert 2021; 35(4): 241-245 Advance Access publication xx December 2021 DOWNLOAD PDF
CASE REPORT From membranoproliferative glomerulonephritis to a final diagnosis: Hypocomplementemic urticarial vasculitis syndrome Joana Marques, Tiago Pereira, Dulce Carvalho, Mário Góis, Helena Sousa, Francisco Ribeiro, Fernando Nolasco
Membranoproliferative glomerulonephritis describes a glomerular-injury pattern common to a heterogeneous group of diseases.
Port J Nephrol Hypert 2021; 35(4): 251-256 Advance Access publication xx December 2021 DOWNLOAD PDF
CASE REPORT The gray area between operational tolerance and overt rejection in kidney transplantation Rui F. Silva, Miguel L. Relvas, Ana Nunes, José L. Silvano, Ana Beco, Manuela B. Bustorff, Susana M. Sampaio
Operational tolerance in kidney transplantation is characterized by stable serum creatinine < 1.7 mg/dL and proteinuria < 1 g/day in the absence of immunosuppression or immunodeficiency for over one year.
Port J Nephrol Hypert 2021; 35(4): 258-260 Advance Access publication 29 December 2021 DOWNLOAD PDF
EDITORIAL Farewell from the editor-in-chief: A short memoir José Vinhas
For 6 years I have had the honor of being the Editor-in-Chief of The Portuguese Journal of Nephrology and Hypertension.
Port J Nephrol Hypert 2021; 35(4): 257 Advance Access publication xx December 2021 DOWNLOAD PDF
LETTER TO THE EDITOR The importance of the first year of kidney transplantation in the presence of left ventricular hypertrophy Ana Carina Ferreira, Aníbal Ferreira
Patients with chronic kidney disease (CKD) are at risk of cardiovascular (CV) disease and increased CV mortality1.
Port J Nephrol Hypert 2021; 35(2): 266-267 Advance Access publication 29 June 2021 DOWNLOAD PDF
NEPHROPATHOLOGY QUIZ Yellish kidney: a case of cast nephropathy Joana Cristóvão Marques, Ana Cunha Rodrigues, Marina Reis, Mário Góis, Helena Sousa
We present a case of a 47-year-old male with past medical history of Wilson disease with neurologic involvement, submitted to liver transplant in 2008.
Port J Nephrol Hypert 2021; 35(4): 263-265 Advance Access publication 30 December 2021 DOWNLOAD PDF
PERSPECTIVE Arguments for an age-adapted definition of chronic kidney disease Pierre Delanaye, Etienne Cavalier
Defining a disease or a pathological status is not easy.
Port J Nephrol Hypert 2021; 35(4): 261-262 Advance Access publication 30 December 2021 DOWNLOAD PDF
PERSPECTIVE Supportive Care Program in CKD: from dream to reality Ana Farinha, Patrícia Valério, Lina Borges, Ana Lourenço
The number of older and frail patients has greatly increased in nephrology departments.
Port J Nephrol Hypert 2021; 35(4): 246-250 Advance Access publication xx December 2021 DOWNLOAD PDF
TUBULAR QUIZ Stones that run in the family Vitória Paes de Faria, Catarina Almeida, Daniela Alferes, Marina Reis, Daniela Lopes, Clara Almeida, Ana Marta Gomes
We present the case of a 48-year-old female patient with a history of calcium and phosphate oxalate urolithiasis and recurrent urinary tract infections who underwent multiple urology surgeries over a 20-year period due to obstructive calculi.
Port J Nephrol Hypert 2021; 35(4): 268-271 Advance Access publication 30 December 2021 DOWNLOAD PDF
Grupo de estudo de Dialise Peritoneal